Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Revenue

Kangmei Pharmaceutical had revenue of 1.28 billion CNY in the quarter ending June 30, 2025, with 0.39% growth. This brings the company's revenue in the last twelve months to 5.29 billion, up 6.45% year-over-year. In the year 2024, Kangmei Pharmaceutical had annual revenue of 5.19 billion with 6.47% growth.

• Revenue (ttm): 5.29B
• Revenue Growth: +6.45%
• P/S Ratio: 5.30
• Revenue / Employee: 1.25M
• Employees: 4,233
• Market Cap: 28.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.19B	315.12M	6.47%
Dec 31, 2023	4.87B	693.87M	16.60%
Dec 31, 2022	4.18B	27.63M	0.67%
Dec 31, 2021	4.15B	-1.26B	-23.27%
Dec 31, 2020	5.41B	-6.03B	-52.72%